STRATA Skin Sciences Community

NasdaqCM:SSKN Community

1 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

STRATA Skin Sciences

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Improved XTRAC Utilization And Expanded International Partnerships Will Secure Success

Key Takeaways Strategic removal of underperforming units and partnerships with clinics enhance device utilization and revenue potential. Growing international sales and TheraClearX adoption, coupled with insurance reimbursements, bolster future revenue prospects.

US$10.00

FV

74.1% undervalued

7.43%

Revenue growth p.a.

0

0

0

2 days ago